[Neurospecific proteins in human malignant brain tumors].
The content of neurospecific proteins S-100, GFA and D2 was measured in malignant cerebral tumors by electrophoresis with the use of monospecific antisera. Concomitant measurement of proteins S-100 and GFA is a more reliable diagnostic criterion as to the tumor histogenesis than study of each protein alone. D2 protein appeared to be the most stable specific marker.
Berezin
V A
VA
Zhmarev
E N
EN
Brodskaia
I A
IA
Shevchenko
G M
GM
Zashko
L S
LS
D001706:Biopsy; D001932:Brain Neoplasms / Q000032:analysis* / Q000175:diagnosis / Q000473:pathology; D002528:Cerebellar Neoplasms / Q000032:analysis; D005904:Glial Fibrillary Acidic Protein; D005910:Glioma / Q000032:analysis; D006023:Glycoproteins / Q000032:analysis; D006801:Humans; D008527:Medulloblastoma / Q000032:analysis; D008577:Meningeal Neoplasms / Q000032:analysis; D008579:Meningioma / Q000032:analysis; D009419:Nerve Tissue Proteins / Q000032:analysis*; D009418:S100 Proteins / Q000032:analysis; D012509:Sarcoma / Q000032:analysis
D005904:Glial Fibrillary Acidic Protein; D006023:Glycoproteins; D009419:Nerve Tissue Proteins; D009418:S100 Proteins; C488879:brain-specific protein D2, human
Neĭrospetsificheskie belki v zlokachestvennykh opukholiakh mozga cheloveka.